Werke:
- Determinants of health-related quality of life decline in interstitial lung disease
- Cost drivers in the pharmacological treatment of interstitial lung disease
- Severe tracheal tear – an alternative extracorporeal membrane oxygenation indication
- Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme